Related Experiment Video
Updated: Mar 24, 2026
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Guillain-Barré syndrome.
Hugh J Willison1, Bart C Jacobs2, Pieter A van Doorn3
1Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Guillain-Barré syndrome is a severe paralytic neuropathy affecting 100,000 annually. Advances in understanding triggers and mechanisms are guiding new treatments and biomarkers for this acute autoimmune neuropathy.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Guillain-Barré syndrome is a significant cause of acute paralytic neuropathy, with global incidence around 100,000 cases yearly.
- It encompasses various subtypes, with severe forms presenting respiratory failure in 20-30% of patients.
- Current optimal management involves intravenous immunoglobulin or plasma exchange, complemented by supportive care.
Purpose of the Study:
- To summarize the current understanding of Guillain-Barré syndrome, including its variants and management.
- To highlight recent advancements in understanding infectious triggers, immunological, and pathological mechanisms.
- To underscore the importance of ongoing collaborative research in developing outcome predictors and biomarkers.
Main Methods:
- Review of current literature on Guillain-Barré syndrome.
- Analysis of data from large, worldwide collaborative studies.
- Focus on advancements in understanding disease mechanisms and treatment efficacy.
Main Results:
- Significant progress in understanding infectious triggers and the immunological basis of Guillain-Barré syndrome.
- Identification of intravenous immunoglobulin and plasma exchange as optimal treatments.
- Initiation of large-scale studies to gather data for outcome predictors and biomarkers.
Conclusions:
- Understanding of Guillain-Barré syndrome's mechanisms has substantially advanced.
- New treatments are being investigated based on improved scientific insights.
- Collaborative research is crucial for developing better diagnostic tools and predicting outcomes for acute autoimmune neuropathies.
More Related Videos
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:26Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:26Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...